?? ??:

1236033-04-7

???:

Ruxolitinib intermediate

???(??):

Ruxolitinib intermediate;Ruxolitinib Impurity 25 (+)-Dibenzoyltartaric Acid Salt;(3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]prop;(R)-3-cyclopenyl-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-l-yl)propanenitrile(2R, 3R)-2,3-bis(benzoyloxy)succinate;(3R)-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile (2S,3S)-2,3-bis(benzoyloxy)succinic acid salt;(2S,3S)-2,3-bis(benzoyloxy)butanedioic acid (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile

CBNumber:

CB03161650

???:

C41H46N6O9Si

??? ??:

794.94

MOL ??:

1236033-04-7.mol